something that is an economic impact then that is quite clearly outside the scope of this estimates that I am required to conduct. Senator CHERRY ?Your web site says you take into regard international developments in your assessments. Given the imminence of the UK crop trials and also the UK science panel report, why was the Bayer application not delayed until those reports were received and assessed? Dr Meek ?Because the UK farm trials were exactly that. They were farm trials and we were considering a commercial release application. I have already explained in considerable detail why the findings of the UK farm trials have very little direct relevance to Australia because our environmental situations are so completely different. Senator CHERRY ?Have you commissioned any research on impact on biodiversity in Australia of GM crops? Dr Meek ?No, we have not. Senator CHERRY ?Are you aware of any peer review studies in Australia that have examined the impact of GM canola and the associated herbicide regime on Australian biodiversity? Dr Meek ?We have looked at some 400 papers in the risk assessment and risk management plan. I would suspect that amongst those there may well have been. Senator CHERRY ?You can take that on notice if you like. I would be interested in the extent to which your office has looked at that issue. Dr Meek ?As I said earlier, if it is to do with a herbicide resistance management issue then that falls firmly within the jurisdiction of the